Blog

A new interesting article has been published in Clin Exp Rheumatol. 2020 Mar-Apr; 38(2):337-342. Epub 2020 Mar 22. Review and titled:

COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?

Authors of this article are:

Sarzi-Puttini P, Giorgi V, Sirotti S, Marotto D, Ardizzone S, Rizzardini G, Antinori S, Galli M.

A summary of the article is shown below:

A severe outbreak of coronavirus disease 2019 (COVID-19) emerged in China in December 2019, and spread so rapidly that more than 200,000 cases have so far been reported worldwide; on January 30, 2020, the WHO declared it the sixth public health emergency of international concern. The two previously reported coronavirus epidemics (severe acute respiratory syndrome [SARS] and Middle East respiratory syndrome [MERS]) share similar pathogenetic, epidemiological and clinical features as COVID-19. As little is currently known about SARS-CoV-2, it is likely that lessons learned from these major epidemics can be applied to the new pandemic, including the use of novel immunosuppressive drugs.

Check out the article’s website on Pubmed for more information:

[link-preview url=https://www.ncbi.nlm.nih.gov/pubmed/32202240 forceshot=true]

This article is a good source of information and a good way to become familiar with topics such as: COVID-19; SARS-COV-2; 2019-nCoV; Coronavirus.

---

New Research Kits from MOLECULAR DEPOT

---

New Antibodies from MOLECULAR DEPOT

---

New Proteins from MOLECULAR DEPOT

---

New Chemicals from MOLECULAR DEPOT